BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33378013)

  • 21. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA SNHG14 aggravates invasion and migration as ceRNA via regulating miR-656-3p/SIRT5 pathway in hepatocellular carcinoma.
    Tang SJ; Yang JB
    Mol Cell Biochem; 2020 Oct; 473(1-2):143-153. PubMed ID: 32607966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Preliminary Investigation of PVT1 on the Effect and Mechanisms of Hepatocellular Carcinoma: Evidence from Clinical Data, a Meta-Analysis of 840 Cases, and In Vivo Validation.
    Zhang Y; Wen DY; Zhang R; Huang JC; Lin P; Ren FH; Wang X; He Y; Yang H; Chen G; Luo DZ
    Cell Physiol Biochem; 2018; 47(6):2216-2232. PubMed ID: 29975928
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long noncoding RNA MAFG-AS1 facilitates the progression of hepatocellular carcinoma via targeting miR-3196/OTX1 axis.
    Hu ZQ; Li HC; Teng F; Chang QM; Wu XB; Feng JF; Zhang ZP
    Eur Rev Med Pharmacol Sci; 2020 Dec; 24(23):12131-12143. PubMed ID: 33336731
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LncRNA HCG18 contributes to the progression of hepatocellular carcinoma via miR-214-3p/CENPM axis.
    Zou Y; Sun Z; Sun S
    J Biochem; 2020 Nov; 168(5):535-546. PubMed ID: 32663252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proliferation and migration of hepatocellular carcinoma are accelerated by LINC01287 via the miR-559/TCF12 axis.
    Song YB; Yu Z; Fu AQ; Zhou DM
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6023-6030. PubMed ID: 32572916
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circular RNA circGFRA1 promotes angiogenesis, cell proliferation and migration of hepatocellular carcinoma by combining with miR-149.
    Yu YX; Ge TW; Zhang P
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(21):11058-11064. PubMed ID: 33215421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long non-coding RNA NEAT1 promotes hepatocellular carcinoma cell proliferation through the regulation of miR-129-5p-VCP-IκB.
    Fang L; Sun J; Pan Z; Song Y; Zhong L; Zhang Y; Liu Y; Zheng X; Huang P
    Am J Physiol Gastrointest Liver Physiol; 2017 Aug; 313(2):G150-G156. PubMed ID: 28526689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
    Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
    Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis.
    Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K
    J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LncRNA BACE1-AS enhances the invasive and metastatic capacity of hepatocellular carcinoma cells through mediating miR-377-3p/CELF1 axis.
    Liu C; Wang H; Tang L; Huang H; Xu M; Lin Y; Zhou L; Ho L; Lu J; Ai X
    Life Sci; 2021 Jun; 275():119288. PubMed ID: 33667514
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CircRNA_0000502 promotes hepatocellular carcinoma metastasis and inhibits apoptosis through targeting microRNA-124.
    Zhang S; Liu Y; Liu Z; Zhang Y; Chen G; Li K; Tang K
    J BUON; 2019; 24(6):2402-2410. PubMed ID: 31983112
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long Non-Coding RNA PVT1/miR-150/ HIG2 Axis Regulates the Proliferation, Invasion and the Balance of Iron Metabolism of Hepatocellular Carcinoma.
    Xu Y; Luo X; He W; Chen G; Li Y; Li W; Wang X; Lai Y; Ye Y
    Cell Physiol Biochem; 2018; 49(4):1403-1419. PubMed ID: 30205391
    [TBL] [Abstract][Full Text] [Related]  

  • 34. miR-654-3p predicts the prognosis of hepatocellular carcinoma and inhibits the proliferation, migration, and invasion of cancer cells.
    Yang J; Zhang Z; Chen S; Dou W; Xie R; Gao J
    Cancer Biomark; 2020; 28(1):73-79. PubMed ID: 32176631
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LncRNA TMPO-AS1 promotes hepatocellular carcinoma cell proliferation, migration and invasion through sponging miR-329-3p to stimulate FOXK1-mediated AKT/mTOR signaling pathway.
    Guo X; Wang Y
    Cancer Med; 2020 Jul; 9(14):5235-5246. PubMed ID: 32462698
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. LINC00174 is an oncogenic lncRNA of hepatocellular carcinoma and regulates miR-320/S100A10 axis.
    Zhao JT; Chi BJ; Sun Y; Chi NN; Zhang XM; Sun JB; Chen Y; Xia Y
    Cell Biochem Funct; 2020 Oct; 38(7):859-869. PubMed ID: 32128852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA SNHG15 promotes hepatocellular carcinoma progression by sponging miR-141-3p.
    Ye J; Tan L; Fu Y; Xu H; Wen L; Deng Y; Liu K
    J Cell Biochem; 2019 Dec; 120(12):19775-19783. PubMed ID: 31310393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. LncRNA LINC00668 promotes cell proliferation, migration, invasion ability and EMT process in hepatocellular carcinoma by targeting miR-532-5p/YY1 axis.
    Xuan W; Zhou C; You G
    Biosci Rep; 2020 May; 40(5):. PubMed ID: 32249890
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RP11-81H3.2 Acts as an Oncogene via microRNA-490-3p Inhibition and Consequential Tankyrase 2 Up-Regulation in Hepatocellular Carcinoma.
    Chen W; Li K; Zhu K; Yan R; Cai QC; Li WH; Dang CX
    Dig Dis Sci; 2020 Oct; 65(10):2949-2958. PubMed ID: 31858324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.